Awakn's Dr Ben Sessa on therapist training and psychedelic healthcare on the NHS
Psychiatrist Dr Ben Sessa, Head of Psychedelic Medicine at Awakn Life Sciences, specialises in addiction services and psychedelic-assisted therapy.
PSYCH spoke with Dr Sessa regarding Awakn’s business model, therapist training and the potential of psychedelic healthcare on the NHS.
‘At Awakn we have two things we do,’ explained Dr Sessa. ‘Research and Development and commercialisation…We have just received approval of a grant from the UK government to cover 66% of the costs of the Phase III trial, which is a fascinating development.’READ MORE